PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,771.00
Bid: 1,770.50
Ask: 1,771.00
Change: -12.50 (-0.70%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Britain's FTSE snaps four-session losing streak

Tue, 27th Mar 2018 17:11

* FTSE 100 up 1.5 pct, approaches 7,000-point level

* Global trade worries ease

* Ferguson jumps after H1 profits

* GlaxoSmithKline advances on Novartis deal(Adds closing prices)

By Kit Rees

LONDON, March 27 (Reuters) - Britain's top share indexrebounded from its lowest level in more than a year on Tuesdayas risk assets breathed a sigh of relief on signs that a globaltrade war could be averted.

The blue-chip FTSE 100 closed 1.5 percent up at6,994.85 points, with almost every constituent in positiveterritory. Mid-cap shares rose by a shade more than 1percent.

A stronger dollar also helped to buoy the index. A weakpound typically supports the FTSE by giving an accounting boostto UK blue-chips companies that have revenue in dollars.

Risk assets came under pressure last week on the back ofworries over escalating global trade tensions after the UnitedStates planned tariffs on up to $60 billion of Chinese goods,with exposed sectors such as basic resources hit hardest.

However, hopes that tensions could ease were sparked byreports that Chinese and U.S. officials were in negotiations toavert a full-blown trade war.

"Suddenly the whole show is looking a lot like a negotiatingtool rather than any serious intention to imitate a trade war,"said Fiona Cincotta, senior market analyst at City Index.

The FTSE 100 has been trading at its lowest levels sinceDecember 2016, posting losses for the past four sessions. So farthe FTSE is down about 9 percent in 2018.

"It comes back to more stock-picking, because last year itwas difficult to lose out as long as you were holding on tosomething," said Mike van Dulken, head of research at AccendoMarkets.

Heating and plumbing products supplier Fergusonposted the best performance, up 6.7 percent after it reported arise in first-half profit and proposed a special dividend andshare consolidation of about $1 billion.

GlaxoSmithKline rose 4.8 percent after thepharmaceuticals group agreed to buy Novartis's stake intheir consumer healthcare joint venture for $13 billion.(Reporting by Kit Rees and Julien PonthusEditing by Peter Graff and David Goodman)

More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.